Presentation is loading. Please wait.

Presentation is loading. Please wait.

BWGIC survey Victor Legrand Yves Taeymans. PCI 2004 : procedures n= 23426.

Published byJoanna Ward Modified over 9 years ago

Similar presentations

Presentation on theme: "BWGIC survey Victor Legrand Yves Taeymans. PCI 2004 : procedures n= 23426."— Presentation transcript:

1 BWGIC survey Victor Legrand Yves Taeymans

2 PCI 2004 : procedures n= 23426

3 Patients characteristics Age : 67+/- 12 years Male : 73.4% Diabetes : 18.3% insulin dep : 5.4% PVD : 10.8 % Renal failure : 2.7% Hx PCI : 27.6% Hx CABG : 11.6% Hx Qwave MI : 18.7% 1VD : 41.6% 2VD : 31.8% 3VD : 23.1% LVEF<35% : 7.1% Shock : 2.1%

4 PCI 2004 : indications n= 23426

5 Number of PCI per center >400 >200>1000

6 PCI for acute STEMI 17 33 50 67 83 100 Mean : 14.9 +/-0.2% 7.3% to 85.7%

7 In-hospital outcomes No MACCE :94% Death :1.6% CVA :0.2% Qwave MI :0.9% nonQwave MI :2.3% CABG :0.4% PCI :0.7% Bleeding :0.5% Vascular complic. :0.6% CPR :0.7% Unplanned dialysis :0.1%

8 > 400 PCI n = 21527 < 400 PCI n = 1899 P value Age (yrs)66±1765±12NS Male15821 (73.5%)1369 (72.1 %)NS Creatinine >22mg/dl589 (2.7 %)47 (2.5 %)NS PVD2302 (10.7 %)198 (10.4 %)NS Diabetes total insuline dep. 3873 (18 %) 1143 (5.3 %) 397 (20.9 %) 120 (6.3 %) 0.002 0.01 Pre MI4001 (18.6 %)391 (20.6 %)0.03 Pre PCI6024 (28 %)444 (23.4 %)0.0001 Pre CABG2505 (11.6 %)207 (10.9 %)NS

9 > 400 PCI n = 21527 < 400 PCI n = 1899 P value STEMI (post lysis) 3095 (14.4 %) 668 (3.10 %) 403 (21.2 %) 110 (5.8 %) 0.0001 UA II C1658 (7.7 %)135 (7.1 %)NS UA II/III B4946 (23 %)476 (25.1 %)0.04 Shock430 (2.0 %)65 (3.4 %)0.0001 3 VD 2 VD 1 VD 5041 (23.4 %) 6921 (32.1 %) 8798 (40.9 %) 379 (19.9 %) 536 (28.2 %) 958 (50.4 %) 0.0007 0.0005 0.0001

10 > 400 PCI n = 21527 < 400 PCI n = 1899 P value PCI RCA (1+2+3+4) LM (5) IVA (6+7) 7154 (33.2 %) 318 (1.5 %) 7014 (32.6 %) 691 (36.4 %) 19 (1.0 %) 603 (31.7 %) 0.006 NS 0.04 GP II b/III a inhibitors4229 (19.6 %)622 (32.7 %)0.0001 IAPB303 (1.4 %)33 (1.7 %)NS Staged PCI 2x 3x 1672 (7.8 %) 148 (0.7 %) 118 (6.2 %) 10 (0.5 %) 0.02 NS

11 >400 PCI n = 21527 < 400 PCI N = 1899 P value Death302 (1.4 %)70 (3.7 %)0.0001 Non QMI456 (2.1 %)81 (4.3 %)0.0001 QMI173 (0.8 %)31 (1.6 %)0.0003 CVA47 (0.2 %)6 (0.3 %)NS Re PCI130 (0.6 %)19 (1.0 %)0.05 CABG70 (0.3 %)16 (0.8 %)0.0007 Dialysis26 (0.1 %)4 (0.2 %)NS Vasc./Bleed. complications224 (1.0 %)13 (0.7 %)NS

12 > 1000 PCI n = 11309 400-1000 PCI n = 10218 200-400 PCI n = 1076 0-200 PCI n = 823 Age (yrs)66 ± 2065 ± 1564 ± 1266 ± 12 Male8285 (73.3 %)7536 (73.7 %)799 (74.2 %)570 (69.2 %) Creat.>22mg289 (2.6 %)300 (2.9 %)16 (1.5 %)31 (3.8 %) PVD1104 (9.8 %)1198 (11.7 %)113 (10.5 %)85 (10.3 %) Diabetes insuline dep. 1904 (16.8 %) 560. (4.9 %) 1969 (19.3 %) 583 (5.7 %) 231 (21.5) 80 (7.4 %) 166 (20.2) 40 (4.9 %) Pre MI1971 (17.4 %)2030 (19.9 %)253 (23.5 %)138 (16.8 %) Pre PCI2901 (25.6 %)3123 (30.6 %)278 (25.8 %)166 (20.2 %) Pre CABG1300 (11.5 %)1205 (11.8 %)123 (11.4 %)84 (10.2 %)

13 > 1000 PCI n = 11309 400-1000 PCI n = 10218 200-400 PCI n = 1076 0-200 PCI n = 823 STEMI (post lysis) 1643 (14.5 %) 410 (25 %) 1452 (14.2 %) 258 (17.8 %) 198 (18.4 %) 31 (15.6 %) 207 (25.1 %) 79 (38.2 %) UA II C829 (7.3 %)829 (8.1 %)77 (7.1 %)58 (7.0 %) UA II/III B2629 (23.2 %)2317 (22.7 %)273 (25.4 %)203 (24.7 %) Shock227 (2 %)203 (2 %)40 (3.7 %)25 (3.0 %) 3 VD 2 VD 1 VD 2676 (23.7 %) 3687 (32.6 %) 4497 (39.8 %) 2365 (23.1 %) 3234 (31.6 %) 4301 (42.1 %) 193 (17.9 %) 293 (27.2 %) 566 (52.6 %) 186 (22.6 %) 243 (29.5 %) 392 (47.6 %)

14 > 1000 PCI n = 11309 400-1000 PCI n = 10218 200-400 PCI n = 1076 0-200 PCI n = 823 PCI RCA(1-4) LM(5) IVA (6+7) 3607 (31.9 %) 200 (1.8 %) 3850 (34.0) 3547 (34.7 %) 118 (1.1 %) 3164 (31.0) 361 (33.6 %) 12 (1.1 %) 375 (34.8 %) 330 (40.1 %) 7 (0.8 %) 228 (27.7 %) GPIIb/IIIa1722 (15.7 %)2507 (24.5 %)346 (31.6 %)276 (33.5 %) IABP148 (1.3 %)155 (1.5 %)19 (1.8 %)14 (1.7 %) Staged PCI 2x 3x 997 (8.8 %) 98 (0.9 %) 675 (6.6 %) 50 (0.5 %) 75 (7.0 %) 6 (0.5 %) 43 (5.2 %) 4 (0.5 %)

15 >1000 PCI n = 11309 400–1000 PCI n = 10218 200 – 400 PCI n = 1076 0-200 PCI n = 823 Death161 (1.42 %)141 (1.38 %)41 (3.81 %)29 (3.52 %) Non QMI246 (2.17 %)210 (2.06 %)51 (4.74 %)30 (3.64 %) QMI36 (0.37 %)137 (1.34 %)20 (1.86 %)11 (1.34 %) CVA28 (0.25 %)19 (0.18 %)4 (0.37 %)2 (0.24 %) Re PCI71 (0.63 %)59 (0.58 %)12 (1.11 %)7 (0.85 %) CABG30 (0.26 %)40 (0.39 %)11 (1.0 %)5 (0.61 %) Dialysis8 (0.07 %)18 (0.18 %)2 (0.18 %)2 (0.24 %) Vasc./ Bleed.67 (0.59 %)157 (1.54 %)11 (1.0 %)2 (0.24 %)

16 Predictors of death multivariate logistic analysis BS.E.WalddfpExp(B) Volume Volume 1 Volume2 Volume3 ASTEMI PCI1Age Sex Cardshk constant.017.977.759 1.805.076.021 3.523 -10.680.134.219.241.130.006.133.138.459 29.279.016 19.946 9.950 192.098 156.846.024 649.263 541.696 311111111311111111.000.901.000.002.000.876.000 1.017 2.655 2.137 6.078 1.079 1.021 33.890.000 Variables entered on step 1 : Volume,ASTEMI,PCI1Age,Sex,Cardshk

17 Predictors of mortality

18 Predictors of MACCE* multivariate logistic analysis BS.E.WalddfpExp(B) Volume Volume 1 Volume2 Volume3 ASTEMI Sex Cardshk PCI1Age constant.184.881.524 1.286.033 -2.158.016 -2.384.066.116.138.067.069.104.003.218 65.530 7.870 57.762 14.344 373.575.222 428.624 34.665 119.785 311111111311111111.000.005.000.637.000 1.202 2.413 1.689 3.617 1.033.116 1.016.092 Variables entered on step 1 : Volume,ASTEMI,Sex,Cardshk,PCI1Age *excluding death

19 Predictors of MACCE* *excluding death

Download ppt "BWGIC survey Victor Legrand Yves Taeymans. PCI 2004 : procedures n= 23426."

Similar presentations

Impact of Anemia on One-Year Ischemic Events and Mortality Among Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention Steven.

Impact of Anemia on One-Year Ischemic Events and Mortality Among Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention Steven.
K Fox, W Remme, C Daly, M Bertrand, R Ferrari, M Simoons On behalf of the EUROPA investigators. The diabetic sub study of.

K Fox, W Remme, C Daly, M Bertrand, R Ferrari, M Simoons On behalf of the EUROPA investigators. The diabetic sub study of.
Comparison of the New Mayo Clinic Risk Scores and Clinical SYNTAX Score in Predicting Adverse Cardiovascular Outcomes following Percutaneous Coronary Intervention.

Comparison of the New Mayo Clinic Risk Scores and Clinical SYNTAX Score in Predicting Adverse Cardiovascular Outcomes following Percutaneous Coronary Intervention.
Comparison of AngioJET Rheolytic Thrombectomy Before Direct Infarct Artery STENTing in Patients with Acute Myocardial Infarction: the JETSTENT trial David.

Comparison of AngioJET Rheolytic Thrombectomy Before Direct Infarct Artery STENTing in Patients with Acute Myocardial Infarction: the JETSTENT trial David.
CPORT- E Trial Randomized trial comparing medical, economic and quality of life outcomes of non-primary PCI at hospitals with and without on-site cardiac.

CPORT- E Trial Randomized trial comparing medical, economic and quality of life outcomes of non-primary PCI at hospitals with and without on-site cardiac.
5 Years Results of Off-Pump VS On-Pump CABG 5 Years Results of Off-Pump VS On-Pump CABG Prospective Non-randomized Comparative Study Piya Cherntanomwong*,

5 Years Results of Off-Pump VS On-Pump CABG 5 Years Results of Off-Pump VS On-Pump CABG Prospective Non-randomized Comparative Study Piya Cherntanomwong*,
STEMI Due to Stent Thrombosis: An Enlarging Subgroup of High Risk Patients Bruce Brodie, Adam Bensimhon, Nathan Fleishman, Charles Hansen, Mike Cooper,

STEMI Due to Stent Thrombosis: An Enlarging Subgroup of High Risk Patients Bruce Brodie, Adam Bensimhon, Nathan Fleishman, Charles Hansen, Mike Cooper,
Impella Technology Elective Support Clinical Evidence and Investigations.

Impella Technology Elective Support Clinical Evidence and Investigations.
WG 2010 1 Hellenic PCI Registry Organization - Structure - Directions - Initial Recordings Georgios I. Papaioannou, MD,

WG Hellenic PCI Registry Organization - Structure - Directions - Initial Recordings Georgios I. Papaioannou, MD,
Validation of Mayo Clinic Risk Adjustment Model for In-Hospital Mortality following Percutaneous Coronary Interventions using the National Cardiovascular.

Validation of Mayo Clinic Risk Adjustment Model for In-Hospital Mortality following Percutaneous Coronary Interventions using the National Cardiovascular.
Around-the-Clock Primary Angioplasty: A Process of Care Analysis Comparing Off-Hours and Normal Hours Treatment of Acute STEMI R Leung, D Lundberg, D Galbraith,

Around-the-Clock Primary Angioplasty: A Process of Care Analysis Comparing Off-Hours and Normal Hours Treatment of Acute STEMI R Leung, D Lundberg, D Galbraith,
Patterns of red blood cell transfusion use and outcomes in patients undergoing percutaneous coronary intervention in contemporary clinical practice: Insights.

Patterns of red blood cell transfusion use and outcomes in patients undergoing percutaneous coronary intervention in contemporary clinical practice: Insights.
Hamon M 1, Nienaber C 2, Galli S 3, Huber K 4, Gulba D 5, Hill J 6, Lafont A 7, Cequier A 8, Bernstein D 9, Deliargyris E 9 Institutions: 1. Centre Hospitalier.

Hamon M 1, Nienaber C 2, Galli S 3, Huber K 4, Gulba D 5, Hill J 6, Lafont A 7, Cequier A 8, Bernstein D 9, Deliargyris E 9 Institutions: 1. Centre Hospitalier.
Angiomax (bivalirudin) in Peripheral Vascular Disease (PVD)

Angiomax (bivalirudin) in Peripheral Vascular Disease (PVD)
ICE 2009 1 Hellenic PCI Registry Organization - Structure - Directions - Initial Recordings Georgios I. Papaioannou, MD,

ICE Hellenic PCI Registry Organization - Structure - Directions - Initial Recordings Georgios I. Papaioannou, MD,
Quality of care: from theory to practice Kim A Eagle MD Albion Walter Hewlett Professor of Internal Medicine Chief, Clinical Cardiology Co-Director, Heart.

Quality of care: from theory to practice Kim A Eagle MD Albion Walter Hewlett Professor of Internal Medicine Chief, Clinical Cardiology Co-Director, Heart.
Cardiac Intervention in the Elderly. Cardiac Interventions Coronary Artery Bypass Grafting (CABG) Percutaneous Transluminal Coronary Angioplasty (PTCA)

Cardiac Intervention in the Elderly. Cardiac Interventions Coronary Artery Bypass Grafting (CABG) Percutaneous Transluminal Coronary Angioplasty (PTCA)
CPORT- E Trial Randomized trial comparing outcomes of non-primary PCI at hospitals with and without on-site cardiac surgery.

CPORT- E Trial Randomized trial comparing outcomes of non-primary PCI at hospitals with and without on-site cardiac surgery.
Female Gender Is An Independent Predictor Of In-Hospital Mortality After STEMI In The Era of Primary PCI. Insights From The Greater Paris Area PCI Registry.

Female Gender Is An Independent Predictor Of In-Hospital Mortality After STEMI In The Era of Primary PCI. Insights From The Greater Paris Area PCI Registry.
Gregg W. Stone, Tim Clayton, Roxana Mehran, Efthymios N. Deliargyris, Jayne Prats, Stuart J. Pocock TCT 2012; JACC 2012;60(17SupplB):B16 The HORIZONS-AMI.

Gregg W. Stone, Tim Clayton, Roxana Mehran, Efthymios N. Deliargyris, Jayne Prats, Stuart J. Pocock TCT 2012; JACC 2012;60(17SupplB):B16 The HORIZONS-AMI.

Similar presentations

Ads by Google